Skip to main content

Table 2 Operative characteristics

From: Aortic valve replacement in pediatric patients: 30 years single center experience

Characteristic

Mechanical AVR

Homograft/bioprosthetic AVR

p value

Aortic valve replacement

   

 Mechanical AVR

22

 Mechanical Bentall

11

 Bioprosthetic AVR

6

 Homograft AVR

21

Valves implanteda

   

 Mechanical/Bentall

  

  Carbomedics

12 (36.4)

  St. Jude Medical

11 (33.3)

  On–X

4 (12.1)

  Duromedics

3 (9.1)

  ATS

2 (6.1)

  Björk-Shiley Monostrut

1 (3)

 Bioprosthetic

  

  Inspiris Resilia

2 (7.4)

  Mosaic

2 (7.4)

  Sorin Pericarbon Stentless

1 (3.7)

  Tissuemed Freestyle Root

1 (3.7)

 Homograft

  

  Homograft bank

15 (55.6)

  Decellularized Corlife

5 (18.5)

  CryoLife homograft

1 (3.7)

Age at time of surgery (years)

13.6 (9.7–15.7)

8.9 (2.4–14.4)

0.004

Weight at time of surgery (kg)

41.7 (24.5–63)

31.5 (12.5–50.2)

0.081

Height at time of surgery (cm)

149 (129–171)

139 (95–158)

0.064

BSAHaycock at time of surgery

1.31 (0.93–1.77)

1.11 (0.56–1.53)

0.105

Median Valve size (mm)

21 (range 17–27)

20 (range 9–25)

0.003

Indication for surgery

  

0.740

 Aortic valve stenosis

1 (3.0)

2 (7.4)

 

 Aortic valve regurgitation

23 (69.7)

17 (63)

 

 Mixed aortic valve lesion

9 (27.3)

8 (29.6)

 

Bacterial endocarditis

2 (6.1)

2 (7.4)

> 0.99

Rheumatic valve disease

3 (9.1)

0 (0)

0.245

Prior cardiac surgery

23 (69.7)

17 (63)

0.596

Prior aortic valve surgery

12 (36.4)

14 (51.9)

0.297

Prior balloon aortic valvuloplasty

3 (9.1)

7 (25.9)

0.097

Time from last surgical aortic valve operation (years)

5 (1.6–7.9)

0.6 (0.04–3.3)

0.006

Operative variable

   

ACCT (min)

95 (66.5–151)

95 (70–129)

0.969

CPB (min)

158 (103–233)

154 (90–235)

0.682

Circulatory arrest

5 (15.2)

1 (3.7)

0.209

Concomitant procedure

16 (48.5)

12 (44.4)

0.799

Aortic annulus enlargement

  

0.745

 Nicks

1 (3)

0 (0)

 

 Manougian

2 (6.1)

0 (0)

 

 Konno

1 (3)

1 (3.7)

 
  1. Values are presented as n, n (%), median (interquartile range) or median (range minimum–maximum) in case of valve size (mm). Continuous variables were compared using the independent-samples Mann–Whitney U test and categorical variables with Fisher exact test
  2. ACCT, Aortic cross clamp time; AVR, aortic valve replacement; BSA, body surface area; ccTGA, congenitally corrected transposition of the great arteries; CPB, cardiopulmonary bypass; VSD, ventricular septum defect
  3. aCarbomedics; Sorin Spa, Milan, Italy; St. Jude Medical; St. Jude Medical Inc, St. Paul, Minn; On-X; On-X Life Technologies Inc, Austin, Tex; Duromedics; Edwards Lifesciences, Irvine Ca; ATS; ATS Medical Inc, Minneapolis, Minn; Björk-Shiley Monostrut; Pfizer Inc, New York, NY; Inspiris Resilia; Edwards Lifesciences, Irvine Ca; Mosaic; Medtronic plc, Dublin, Ireland; Sorin Pericarbon Stentless; Sorin Spa, Milan, Italy; Tissuemed Freestyle Root; Tissuemed, Leeds, England; Decellularized Corlife; Corlife, Hannover, Germany; CryoLife; CryoLife, Kennesaw, GA